Table 3. Antiproliferative Activities of Compounds 6a–b and 6h–j against KYSE520, OE33, Ca9-22, TR-146, and U266B Cell Lines after 48–72 h of Drug Treatment.
IC50 (μM)a | |||||
---|---|---|---|---|---|
compd | KYSE520 | OE33 | Ca9-22 | TR-146 | U266B |
6a | 197 | 17.73 | >1000 | >1000 | |
6b | 12.76 | 5.56 | 19 | 18 | |
6c | >1000 | >1000 | |||
6h | 33.81 | 13.82 | >1000 | 54 | |
6i | 55 | >1000 | 59.38 | ||
6j | 37.83 | >1000 | 133 | 20.25 |
Each value is the mean of at least three determinations.